Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

1.0K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.0K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.6K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

230
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
230
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

966
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
966
Antibiotic Selection00:57

Antibiotic Selection

59.2K
Overview
59.2K
Pneumonia IV: Management01:28

Pneumonia IV: Management

685
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
685

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunoglobulin A vasculitis in association with invasive meningococcal disease.

Modern rheumatology case reports·2026
Same author

The Queensland Bloodstream Infections (QBSI) study: rationale, protocol development and future directions.

Infectious diseases (London, England)·2026
Same author

Management and follow-up of patients with infective endocarditis: an international cross-sectional survey.

Revista espanola de cardiologia (English ed.)·2026
Same author

Emergence of carbapenem-resistant putative hypervirulent <i>Klebsiella pneumoniae</i> ST147 with a distinct hybrid plasmid in Türkiye.

Emerging microbes & infections·2026
Same author

Quality indicators for clinical infectious diseases consultations-results from a hybrid Delphi-nominal group approach and scenario study.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2026
Same author

Current Epidemiology and Infection Characteristics of Non-Aspergillus Mold Infections: A Multicenter Study in Australia and New Zealand.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Related Experiment Video

Updated: Dec 28, 2025

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

5.2K

New treatment options for multiresistant gram negatives.

David L Paterson1,2, Burcu Isler1,3, Adam Stewart1,2

  • 1University of Queensland Centre for Clinical Research.

Current Opinion in Infectious Diseases
|February 19, 2020
PubMed
Summary

New therapies are emerging for multidrug-resistant Gram-negative bacterial infections, offering alternatives for ESBL and carbapenemase-producing Enterobacterales. However, treatment for metallo-beta-lactamase producers and carbapenem-resistant Acinetobacter baumannii remains a critical unmet need.

More Related Videos

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

27.4K
Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance
06:42

Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance

Published on: September 27, 2024

2.6K

Related Experiment Videos

Last Updated: Dec 28, 2025

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations
11:15

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

5.2K
Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method
12:03

Antimicrobial Synergy Testing by the Inkjet Printer-assisted Automated Checkerboard Array and the Manual Time-kill Method

Published on: April 18, 2019

27.4K
Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance
06:42

Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance

Published on: September 27, 2024

2.6K

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Pharmacology

Background:

  • Multidrug-resistant (MDR) Gram-negative bacteria pose a significant global health threat.
  • The rise of resistance necessitates the development of novel therapeutic agents.

Purpose of the Study:

  • To review clinical and preclinical data on new drugs for MDR Gram-negative infections.
  • Focus on agents targeting ESBL and carbapenemase-producing Enterobacterales, carbapenem-resistant Pseudomonas aeruginosa, and carbapenem-resistant Acinetobacter baumannii.

Main Methods:

  • Literature review of recently approved drugs and those in clinical development.
  • Analysis of efficacy and safety data for emerging antimicrobial agents.

Main Results:

  • Several agents active against ESBL and carbapenemase producers are in late-stage development, sparing carbapenems.
  • New beta-lactam/beta-lactamase inhibitor combinations offer safer alternatives for KPC, OXA-48, and carbapenem-resistant P. aeruginosa.
  • Metallo-beta-lactamase (MBL) producers and carbapenem-resistant A. baumannii remain challenging, with limited treatment options currently available.

Conclusions:

  • The armamentarium against MDR Gram-negatives is expanding, particularly for ESBL and KPC producers.
  • Prioritization of research and clinical trials for MBL producers and carbapenem-resistant A. baumannii is crucial.
  • Further clinical trials are needed to evaluate new agents against severe MDR Gram-negative infections.